Delivery Order SPE2DB24D3014-SPE2DB25FKUKJ
- Not listed
- The Defense Logistics Agency awarded a $4,554.55 delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of AJOVY 225 mg/1.5 mL auto-injector units. The contract is classified as a firm fixed price delivery order with an ultimate completion date of August 4, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award utilized no set-aside provisions, reflecting the competitive nature of the procurement. AmerisourceBergen Drug Corp, a...
- This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of AJOVY 225 MG/1.5 ML AUTOINJECT 1.5ML, a migraine medication. The contract has a Firm Fixed Price of $1,407.36 and an ultimate completion date of November 14, 2024. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,847.18 to AmerisourceBergen Drug Corp's Corporate Office Division for the supply of AJOVY 225 MG/1.5 ML AUTOINJECT 1.5ML, a pharmaceutical product. This order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which provides a comprehensive range of medical commodities to support military treatment programs and facilities...
- The Defense Logistics Agency awarded a $696.66 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 1.5ml autoinjectors containing 225mg of AJOVY. As the prime contractor, Amerisourcebergen will deliver the autoinjectors from its facility in Conshohocken, Pennsylvania by August 29, 2023 in support of DLA's medical supply needs. No subcontractors or set aside designations were indicated. DLA manages the global supply chain for the U.S. military and this order...
- This is a $17,518.91 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of AJOVY 225 MG/1.5 ML AUTOINJECT 1.5ML, a prescription medication, with a period of performance through May 16, 2025. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the provision of 225 mg/1.5 mL AJOVY autoinjectors, a medication used to prevent migraine headaches. The contract has a ceiling value of $4,677.37 and a period of performance ending on June 10, 2025. The award is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,657.95, is for the delivery of AJOVY 225 MG/1.5 ML AUTOINJECT 1.5ML, a pharmaceutical product. The contract has a period of performance through February 5, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,052.35, is for the delivery of the medication AJOVY 225 MG/1.5 ML AUTOINJECT 1.5ML. The contract is a firm fixed-price delivery order, with a period of performance through April 18, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at approximately $720 to Amerisourcebergen Drug Corporation to supply AJOVY 225 MG/1.5 ML autoinjectors. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period of one day, from August 10th through the 11th of 2023. As a major distributor of pharmaceuticals and medical supplies for the Department of Defense, this order indicates DLA's continued procurement of migraine...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distributor AmerisourceBergen Corporation. The $1,037.92 firm fixed price delivery order is for the supply of the pharmaceutical product AJOVY 225 MG/1.5 ML AUTOINJECT 1.5ML, with a period of performance through April 3, 2024. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00 through...
- SPE2DB24D3014Indefinite Delivery Contract
- SPE2DB24D3014-SPE2DB25FKUKJDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of AJOVY 225 mg/1.5 mL auto-injector medication, valued at $1,300.58. This is a firm fixed-price delivery order with no set-aside designation, executed competitively under the company's larger indefinite delivery contract (IDC) vehicle with DLA Troop Support Medical. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 21, 2025. This delivery order is a child contract under AmerisourceBergen Drug Corp's prime IDC (SPE2DX) with the DLA Troop Support Medical, which is valued at $999,999,999.00 and extends through December 2026. The parent contract serves as a comprehensive global pharmaceutical support vehicle that enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including customers such as the Defense Health Agency and the U.S. Coast Guard. The current delivery order for AJOVY, a medication used for migraine prevention, exemplifies the company's role as a critical vendor in the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 8/20/25 |